CAMEO: Pediatric Crohn's Disease Outcomes Study



Subscribe to be notified of changes or updates to this page.

14 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This two-phase study is being conducted to determine the reasons why some children with newly diagnosed Crohn's disease heal their bowel inflammation after one type of therapy and why others do not. To do this, the study team will ask to collect blood, stool and biopsy (tissue) samples from participants newly diagnosed with Crohn's disease to measure their inflammation markers and evaluate their genes (DNA). To determine how much a participant's bowels have healed, we will also compare colonoscopy and MRE results that occur as part of the participant's standard clinical care. 

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at kisendam [at] or 267-693-6568. Identifier

Eligibility & Criteria

IRB #:
Official Title:
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease
Study Phase:
Not Applicable
Eligible Age Range:
6 - 17 Years
Study Categories: